Scientific Sessions
  • #AHA23
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Program
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Program
Resources
  • #AHA23
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 12th, 2020

National Heart Failure Initiative will improve outcomes and quality of life for patients with HF

Initiative supported by founding sponsor Novartis and national sponsor Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA, LLC.


2020 11 12 14 11 02

By 2030, more than 8 million people in the U.S. are projected to have heart failure, and deaths from HF are the primary cause of the plateau in age-adjusted death rate from CVD overall. In response,  AHA CEO Nancy Brown has announced the AHA’s National Heart Failure Initiative supported by founding sponsor Novartis and national sponsor Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA, LLC.

The initiative will enhance early identification and optimal treatment of HF, along with patient education, to increase healthy time at home and reduce all-cause mortality by 5%. The extensive expertise and infrastructure of the AHA, scientific partners and industry funders will be leveraged to develop concurrent interventions at several points along the patient care spectrum, including clinical and community touch points, specifically:

  • Establish and support learning health care system using quality improvement infrastructure with real-time feedback for identification of key areas for improvement and evaluation of evidence-based approaches.
  • Develop, implement and evaluate scalable patient empowerment and engagement tools that include personalized technology solutions and facilitate improved access to health care.

The initiative will use established AHA approaches of primary data collection, including the Get With The Guidelines® - HF program, to identify, implement and evaluate processes and develop new standards for HF patient management. Both health care and patient interventions will produce large-scale data collection from in-patient, out-patient and community settings resulting in generation of real-world evidence that will be used for characterization and dissemination of best practices.

Interesting Stories
From Routine To Complex
Sponsored by Jefferson Health
From Routine To Complex
Guideline for the Management of Patients With Chronic Coronary Disease
Sponsored by American Heart Association
Guideline for the Management of Patients With Chronic Coronary Disease
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
Sponsored by American Heart Association
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
More Content
Maxresdefault 65561fbdb9acc
AHA23
Watch: Scientific Sessions 2023 Day 2 | Sunday, Nov. 12
Nov 16th, 2023
Panel of speakers
AHA23
Getting to the Heart of Stroke™
Nov 15th, 2023
Hqdefault 6554fd1be4044
AHA23
Watch: Scientific Sessions 2023 | Day 1, Saturday, Nov. 11
Nov 15th, 2023
Maxresdefault 6554fad25bb7c
AHA23
Watch: Scientific Sessions 2023 Pre-Sessions Symposia & Early Career Day
Nov 15th, 2023
Audience shot
AHA23
Late-breaking science| Achieving equity in prevention
Nov 15th, 2023
audience shot
AHA23
Novel mechanisms for lipid-lowering therapy
Nov 14th, 2023
LBS 08 panelists
AHA23
Late-breaking science: AI at the bedside
Nov 14th, 2023
Lbs05 Panel Web
AHA23
Shocking decisions in AFib care
Nov 13th, 2023
Lbs04 Panel2 Web
AHA23
Drugs, diet and delivery can optimize hypertension outcomes
Nov 13th, 2023
Jane E. Freedman, MD, Ann Marie Schmidt, MD, M. Benjamin Shoemaker, MD, MSCI, J. Kevin Donahue, MD
AHA23
Established lecture to present new research developments
Nov 13th, 2023
Randi Foraker, PhD, MA, FAHA, FAMIA, Jessica L. Mega, MD, MPH
AHA23
Artificial intelligence shows promise and pitfalls
Nov 13th, 2023
Clyde W. Yancy, MD, MSc, MACC, FAHA, and Reinier Boon, PhD
AHA23
Age: Is it a number, or a biology?
Nov 13th, 2023